Gudbjorg Edda Eggertsdottir
Gudbjorg Edda Eggertsdottir was born in 1951 and is a private investor. Her previous positions include President & EVP Strategic Projects of Actavis Plc in Iceland, a global integrated specialty pharmaceutical company; Deputy CEO and EVP Third Party Sales at Actavis Group hf.; Deputy CEO, Head of R&D, Assistant Managing Director, Development Manager, Regulatory Manager and Marketing Manager at Delta hf.; and Medical Representative at Pharmaco hf. She was a board member of of the European Generic Medicines Association (now Medicines for Europe) from 2006-2014, including the President 2011-2013. Her board experience is extensive, currently including seats as chairman of the board of Brunnur Ventures Investment Fund, Florealis ehf., as well as Director of Orf Genetics hf., Mentis Cura ehf., Mentis Cura AS, Vistor hf., Heilsulausnir ehf., Saga Natura ehf. and Pretium ehf. Ms. Eggertsdóttir holds a M.Sc. (Pharm.) from Copenhagen University (1976).